Murdoch Children's Research Institute, Parkville, Australia; Department of Paediatrics, University of Melbourne, Parkville, Australia.
School of Population and Global Health, University of Melbourne, Parkville, Australia; Neuroepidemiology Research Group, Florey Institute for Neuroscience and Mental Health, Parkville, Australia.
J Allergy Clin Immunol. 2019 Nov;144(5):1327-1335.e5. doi: 10.1016/j.jaci.2019.07.032. Epub 2019 Aug 8.
Randomized controlled trials demonstrate that timely introduction of peanut to infants reduces the risk of peanut allergy. However, much debate remains regarding how to best achieve earlier peanut introduction at the population level. Our previous study in 2007-2011 (HealthNuts, n = 5300) indicated that few infants were consuming peanut in the first year. Australian infant feeding guidelines were updated in 2016 to recommend introducing peanut before 12 months for all infants. There were no data available on the subsequent effect on peanut introduction or peanut reactions.
We sought to assess the consequences of a nonscreening approach to allergenic food introduction in a population-based sample of infants in their first year of life.
EarlyNuts is a population-based, cross-sectional study of 12-month-old infants in Melbourne, Australia, recruited by using an identical sampling frame and methods to HealthNuts (72% response rate vs 73% response rate in HealthNuts). We report here on the first 860 participants recruited between November 2016 and October 2018.
Most infants (88.6%; 95% CI, 86.1% to 90.7%) had introduced peanut by 12 months (median age, 6 months), an increase from 28.4% (95% CI, 27.2% to 29.7%) in the HealthNuts study. By 12 months, the majority of these (76.4%) had consumed peanut more than 4 times, and 28% were eating peanut more than once per week. Preliminary results on parent-reported reactions show that 4.0% of those consuming peanut by 12 months had possible IgE-mediated reactions.
There has been a striking shift toward earlier peanut introduction, with a 3-fold increase in peanut introduction by age 1 year in 2018 compared with 2007-2011.
随机对照试验表明,及时向婴儿引入花生可降低花生过敏的风险。然而,在人群层面上如何最好地实现更早引入花生仍存在很大争议。我们之前在 2007-2011 年进行的研究(HealthNuts,n=5300)表明,很少有婴儿在一岁内食用花生。澳大利亚婴儿喂养指南于 2016 年更新,建议所有婴儿在 12 个月前引入花生。关于此后对引入花生或花生反应的影响,尚无数据。
我们旨在评估在一项基于人群的 1 岁以下婴儿中,非筛选方法引入致敏性食物的后果。
EarlyNuts 是一项基于人群的横断面研究,研究对象为澳大利亚墨尔本的 12 个月大的婴儿,采用与 HealthNuts 相同的抽样框架和方法(响应率分别为 72%和 73%)。我们在此报告了 2016 年 11 月至 2018 年 10 月间招募的前 860 名参与者。
大多数婴儿(88.6%;95%CI,86.1%至 90.7%)在 12 个月时(中位数年龄为 6 个月)已经引入了花生,高于 HealthNuts 研究中的 28.4%(95%CI,27.2%至 29.7%)。到 12 个月时,其中大多数(76.4%)已经食用花生超过 4 次,28%的人每周食用花生超过 1 次。关于父母报告的反应的初步结果显示,在 12 个月时食用花生的人中,有 4.0%可能存在 IgE 介导的反应。
花生引入的时间明显提前,与 2007-2011 年相比,2018 年 1 岁时引入花生的比例增加了 3 倍。